These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7677857)

  • 21. [Is it necessary to systematically treat diabetics with ACE inhibitors?].
    Marre M; Collet C; Stevenin C
    Journ Annu Diabetol Hotel Dieu; 2001; ():185-7. PubMed ID: 11565461
    [No Abstract]   [Full Text] [Related]  

  • 22. Meeting on diabetic complications and early treatment using ACE inhibitors.
    Barnett AH; Agardh CD
    J Diabetes Complications; 1996; 10(3):124-4. PubMed ID: 8924719
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-induced hypoglycaemia in type 2 diabetes.
    Inkster B; Zammitt NN; Frier BM
    Expert Opin Drug Saf; 2012 Jul; 11(4):597-614. PubMed ID: 22690846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypoglycemia caused by interference between an angiotensin-converting enzyme inhibitor and a hypoglycemic sulfonamide].
    Veyre B; Ginon I; Vial T; Dragol F; Daumont M
    Presse Med; 1993 Apr; 22(15):738. PubMed ID: 8511130
    [No Abstract]   [Full Text] [Related]  

  • 25. [ACE inhibitors, yes or no?].
    Jenssen TG
    Tidsskr Nor Laegeforen; 1995 Oct; 115(24):3014-5. PubMed ID: 7570527
    [No Abstract]   [Full Text] [Related]  

  • 26. ACE inhibitor use and the long-term risk of renal failure in diabetics.
    Woo KT; Lau YK; Wong KS; Chan CM
    Kidney Int; 2006 Oct; 70(7):1376-7; author reply 1378. PubMed ID: 16988741
    [No Abstract]   [Full Text] [Related]  

  • 27. ACE inhibitor use and the increased long-term risk of renal failure in diabetes.
    Hamming I; Goor Hv; Navis GJ
    Kidney Int; 2006 Oct; 70(7):1377-8; author reply 1378. PubMed ID: 16988743
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetes mellitus: Relevance to dental treatment.
    Vernillo AT
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):263-70. PubMed ID: 11250621
    [No Abstract]   [Full Text] [Related]  

  • 29. ACE-inhibitor use and the long-term risk of renal failure in diabetes.
    Suissa S; Hutchinson T; Brophy JM; Kezouh A
    Kidney Int; 2006 Mar; 69(5):913-9. PubMed ID: 16518351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE inhibition in cardiovascular disease.
    Francis GS
    N Engl J Med; 2000 Jan; 342(3):201-2. PubMed ID: 10639547
    [No Abstract]   [Full Text] [Related]  

  • 31. Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure.
    Mandal AK; Markert RJ; Saklayen MG; Mankus RA; Yokokawa K
    Clin Nephrol; 1994 Sep; 42(3):170-4. PubMed ID: 7994935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypoglycemia].
    Fagulha A
    Acta Med Port; 1989 Sep; Suppl 1():25S-26S. PubMed ID: 2694771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Malde B; Regalado J; Greenberger PA
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):57-63. PubMed ID: 17225721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Inquiry: Do ACE inhibitors or ARBs help prevent kidney disease in patients with diabetes and normal BP?
    Trietley GS; Wilson SA; Chaudhri P; Payette N; Higbea A; Nashelsky J
    J Fam Pract; 2017 Apr; 66(4):257-263. PubMed ID: 28375400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes.
    Scarsi KK; Bjornson DC
    Ann Pharmacother; 2000 Sep; 34(9):1002-6. PubMed ID: 10981244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of new stroke or new myocardial infarction or death at 39-month follow up in patients with diabetes mellitus, hypertension, or both treated with and without angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Ravipati G; Aronow WS; Ahn C; Alappat RM; McClung JA; Weiss MB
    Am J Ther; 2009; 16(1):2-4. PubMed ID: 19114876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes.
    Pedersen-Bjergaard U; Agerholm-Larsen B; Pramming S; Hougaard P; Thorsteinsson B
    Diabetologia; 2003 Jan; 46(1):89-96. PubMed ID: 12637987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system.
    Segal A
    N Engl J Med; 2004 Dec; 351(23):2450-1; author reply 2450-1. PubMed ID: 15575066
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypoglycaemic: prevention, consequences and management.
    Shah SN
    J Indian Med Assoc; 2002 Mar; 100(3):166-7, 170. PubMed ID: 12408276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and assessment of hypoglycemia in patients with diabetes mellitus].
    Scheen AJ
    Rev Med Liege; 2014 Feb; 69(2):110-5. PubMed ID: 24683833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.